Avidity
Ania W. currently serves as Associate Director - Accounting at Avidity Biosciences, Inc. since November 2023, following a progressive career at Viasat Inc. from September 2017 to November 2023, where Ania held multiple roles including Manager - Corporate Accounting. Prior professional experience includes positions at PwC as an Experienced Associate in the TICE group, and assurance internships at Porter Keadle Moore and Carr, Riggs & Ingram, where Ania gained valuable experience in internal audits and field audits across various industries. Ania holds a Master of Professional Accountancy from Bryant University and a Bachelor of Business Administration in Accounting from Georgia Southern University.
This person is not in any teams
This person is not in any offices
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.